Therefore, our study on SMOC2 offers novel mechanistic insight about EMT metastasis in RCC and provides an important rationale to potentially monitor and target SMOC2 as a RCC biomarker and therapeutic. Here, SMOC2 is linked to renal cell carcinoma.